Commence the DLCO clinical study
Not delivered by the deadline
AI-assessed · human review in progress Found and assessed by AI from the cited sources. Shown with its evidence; it is not counted in any Kept Score until confirmed.
- Announced
- 16 Feb 2021
- Due
- 30 Jun 2021
- Checked
- 25 Oct 2026
- Deadline
- Met
- Late
- Not met
- Today
What the company said
“Diffusion plans to commence the DLCO Study in the second quarter of 2021”
What we found
Evidence strength A What the grades mean
The company failed to commence the DLCO study in the second quarter of 2021 as planned, eventually commencing it in December 2021.
-
A Diffusion Pharmaceuticals Inc. 8-K filed 2021-06-30
“Diffusion anticipates initiating and completing the DLCO and Altitude Trials in the second half of 2021” ✓ confirmed on the page
-
A Diffusion Pharmaceuticals Inc. 10-Q filed 2022-05-12
“Enrollment of patients in the ILD-DLCO Trial, which commenced in December 2021, continued in the first quarter.” ✓ confirmed on the page
Checked 25 Oct 2026.
Commitment DNA
The structured record of this commitment. Fields the company did not state are left blank rather than guessed.
- Event type
- Project other
- Indicative materiality
- Low rules
- Action
- Commence
- Deliverable
- DLCO Study
- Language
- Expected (“expects”, “plans”)
- In the company’s control
- Medium
- Specificity
- High
- Depends on
- Regulatory
How this entry was checked
- Commitment recordedThe company's words were matched word for word against the filing.
- First checkAn AI model, Gemini (Google), read the company's later filings and recorded the outcome with a quoted passage.
- Second check: disagreesClaude (Anthropic) re-read the evidence blind and read it as “Late”.
- Tie-breakA stronger model read the evidence and both earlier answers, without knowing which was recorded, and agrees with the second check.
Not yet confirmed. Shown on the record, but it will not count in any score until it is confirmed. How verification works
Are you Diffusion Pharmaceuticals Inc.? You can publish an official statement next to this entry, free. Add a statement.
Is something here wrong or out of date? Companies and readers can ask us to check it. Please bring a link to a public source.
Report an error in this entry Reference: KI-C-2021-CRVO-023895 · Corrections policy